Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free CTNM Stock Alerts

Contineum Therapeutics (CTNM) Institutional Ownership

Contineum Therapeutics logo
$15.49 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$15.46 -0.03 (-0.19%)
As of 07/31/2026 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)

Number of
Institutional Buyers
(last 12 months)
50
Total
Institutional Inflows
(last 12 months)
$156.85M
Number of
Institutional Sellers
(last 12 months)
13
Total
Institutional Outflows
(last 12 months)
$16.48M
Get CTNM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CTNM Institutional Buying and Selling by Quarter

Contineum Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP27,054$353K0.1%N/A0.072%
5/29/2026Perceptive Advisors LLC1,255,592$16.40M0.3%-14.3%3.358%
5/19/2026Bank of America Corp DE47,449$620K0.0%+411.9%0.127%
5/19/2026Janus Henderson Group PLC2,734,836$35.59M0.0%+11.7%7.314%
5/18/2026ADAR1 Capital Management LLC276,661$3.61M0.2%-0.8%0.740%
5/18/2026Royal Bank of Canada5,794$76K0.0%+73.5%0.015%
5/18/2026Eversept Partners LP146,411$1.91M0.1%+6.5%0.392%
5/15/2026OMERS ADMINISTRATION Corp14,200$185K0.0%-59.3%0.038%
5/14/2026Renaissance Technologies LLC69,400$906K0.0%+21.5%0.186%
5/7/2026Dimensional Fund Advisors LP59,946$782K0.0%N/A0.161%
5/6/2026 Independent Financial Group LLC27,021$353K0.0%N/A0.072%
4/21/2026 Cannon Global Investment Management LLC13,000$170K0.3%N/A0.035%
2/18/2026Ikarian Capital LLC282,874$3.23M0.3%N/A0.969%
2/18/2026Sphera Funds Management LTD.173,475$1.98M0.4%N/A0.594%
2/18/2026Suvretta Capital Management LLC2,841,334$32.48M0.7%+65.2%9.736%
2/18/2026Quadrature Capital Ltd23,377$267K0.0%N/A0.080%
2/18/2026Occudo Quantitative Strategies LP15,036$172K0.0%N/A0.052%
2/18/2026Perceptive Advisors LLC1,464,592$16.74M0.3%+105.0%5.019%
2/18/2026Millennium Management LLC830,687$9.50M0.0%+24.9%2.846%
2/18/2026Janus Henderson Group PLC2,448,979$27.91M0.0%N/A8.392%
2/18/2026Eversept Partners LP137,493$1.57M0.1%+2.1%0.471%
2/18/2026Commodore Capital LP816,326$9.33M0.6%N/A2.797%
2/18/2026Balyasny Asset Management L.P.1,842,800$21.06M0.0%+93.7%6.315%
2/18/2026Baker BROS. Advisors LP1,420,838$16.24M0.1%+1,729.3%4.869%
2/18/2026Boothbay Fund Management LLC72,494$829K0.0%N/A0.248%
2/18/2026Bridgeway Capital Management LLC49,280$563K0.0%+18.5%0.169%
2/18/2026683 Capital Management LLC91,442$1.05M0.0%N/A0.313%
2/17/2026ADAR1 Capital Management LLC278,961$3.19M0.2%+257.8%0.956%
2/17/2026Schonfeld Strategic Advisors LLC22,673$259K0.0%+22.6%0.078%
2/17/2026RA Capital Management L.P.2,179,711$24.91M0.3%+2.7%7.470%
2/17/2026Trexquant Investment LP59,031$675K0.0%+101.4%0.202%
2/17/2026Price T Rowe Associates Inc. MD11,300$130K0.0%N/A0.039%
2/17/2026ExodusPoint Capital Management LP51,028$583K0.0%N/A0.175%
2/17/2026Graham Capital Management L.P.17,074$195K0.0%N/A0.059%
2/17/2026Persistent Asset Partners Ltd13,853$158K0.1%N/A0.047%
2/17/2026RBF Capital LLC20,000$229K0.0%-50.0%0.069%
2/16/2026OMERS ADMINISTRATION Corp34,900$399K0.0%N/A0.120%
2/16/2026Barclays PLC59,507$680K0.0%+818.9%0.204%
2/13/2026Marshall Wace LLP180,804$2.07M0.0%-6.6%0.620%
2/13/2026Hudson Bay Capital Management LP25,938$296K0.0%N/A0.089%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
2/13/2026State Street Corp84,428$965K0.0%+35.2%0.289%
2/12/2026Renaissance Technologies LLC57,100$653K0.0%+38.6%0.196%
2/12/2026Monashee Investment Management LLC137,430$1.57M0.9%N/A0.471%
2/11/2026Franklin Resources Inc.1,879,367$21.48M0.0%+13.5%6.441%
2/10/2026Goldman Sachs Group Inc.105,594$1.21M0.0%+250.4%0.362%
2/9/2026Geode Capital Management LLC213,869$2.45M0.0%+1.3%0.733%
1/29/2026UBS Group AG199,389$2.28M0.0%+191.1%0.683%
1/29/2026 China Universal Asset Management Co. Ltd.3,764$43K0.0%N/A0.013%
11/17/2025Susquehanna International Group LLP204,119$2.40M0.0%+914.0%0.700%
11/17/2025RA Capital Management L.P.2,122,000$24.93M0.3%N/A7.272%
11/17/2025Baker BROS. Advisors LP77,670$913K0.0%-75.1%0.266%
11/17/2025Bank of America Corp DE7,236$85K0.0%+500.0%0.025%
11/14/2025Schonfeld Strategic Advisors LLC18,496$217K0.0%-88.7%0.063%
11/14/2025ADAR1 Capital Management LLC77,961$916K0.1%-53.3%0.267%
11/14/2025Balyasny Asset Management L.P.951,320$11.18M0.0%N/A3.260%
11/14/2025Two Sigma Investments LP37,943$446K0.0%-37.8%0.130%
11/14/2025Bridgeway Capital Management LLC41,580$489K0.0%+116.6%0.142%
11/14/2025Squarepoint Ops LLC13,086$154K0.0%-85.4%0.045%
11/13/2025UBS Group AG68,504$805K0.0%+793.7%0.235%
11/13/2025Franklin Resources Inc.1,655,548$19.45M0.0%-2.5%5.674%
11/7/2025Vanguard Group Inc.964,232$11.33M0.0%+29.6%3.439%
10/30/2025 Bailard Inc.12,350$145K0.0%N/A0.044%
10/23/2025 Baker Ellis Asset Management LLC19,500$229K0.0%N/A0.070%
8/19/2025Marex Group plc11,400$45K0.0%N/A0.041%
8/15/2025Perceptive Advisors LLC699,486$2.78M0.2%-51.5%2.704%
8/15/2025Bridgeway Capital Management LLC19,200$76K0.0%N/A0.074%
8/14/2025Jane Street Group LLC20,321$81K0.0%N/A0.079%
8/14/2025RBF Capital LLC40,000$159K0.0%N/A0.155%
8/14/2025Qube Research & Technologies Ltd10,924$43K0.0%N/A0.042%
8/13/2025Marshall Wace LLP28,685$114K0.0%-7.7%0.111%
8/13/2025Saturn V Capital Management LP319,348$1.27M0.5%-43.1%1.234%
8/13/2025Norges Bank169,729$674K0.0%N/A0.656%
8/12/2025Franklin Resources Inc.1,698,825$6.74M0.0%+7.8%6.567%
8/11/2025Versant Venture Management LLC542,628$2.15M2.6%-40.9%2.098%
8/8/2025Geode Capital Management LLC71,303$283K0.0%-63.1%0.276%
8/7/2025Monaco Asset Management SAM75,000$298K0.1%N/A0.290%
8/1/2025 Y Intercept Hong Kong Ltd35,156$140K0.0%N/A0.136%
6/27/2025Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055%
5/28/2025Strs Ohio3,900$27K0.0%N/A0.015%
5/16/2025Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055%
5/16/2025Dynamic Technology Lab Private Ltd16,838$118K0.0%N/A0.065%
5/16/2025ADAR1 Capital Management LLC168,765$1.18M0.2%+105.2%0.652%
5/13/2025Altium Capital Management LLC303,857$2.12M5.1%-9.0%1.174%
5/12/2025Nuveen LLC13,307$93K0.0%N/A0.051%
5/9/2025Charles Schwab Investment Management Inc.51,202$357K0.0%-7.5%0.198%
2/17/2025Squarepoint Ops LLC217,239$3.18M0.0%-37.9%0.843%
2/17/2025Stempoint Capital LP265,833$3.89M1.0%N/A1.031%
2/17/2025Red Tree Management LLC638,158$9.35M6.2%N/A2.475%
2/17/2025Polar Capital Holdings Plc43,604$639K0.0%-79.9%0.169%
2/17/2025Nuveen Asset Management LLC13,307$195K0.0%N/A0.052%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,860$86K0.0%+90.4%0.023%
2/17/2025Janus Henderson Group PLC68,320$1.00M0.0%N/A0.265%
2/17/2025Deutsche Bank AG16,079$236K0.0%N/A0.062%
2/17/2025Bank of America Corp DE9,132$134K0.0%+63.4%0.035%
2/14/2025Schonfeld Strategic Advisors LLC125,995$1.85M0.0%N/A0.489%
2/14/2025Northern Trust Corp89,262$1.31M0.0%+42.3%0.346%
2/14/2025MetLife Investment Management LLC7,029$103K0.0%N/A0.027%
2/14/2025Altium Capital Management LLC334,000$4.89M1.4%-9.5%1.296%
2/13/2025Marshall Wace LLP10,836$159K0.0%N/A0.042%
2/13/2025Strategies Wealth Advisors LLC25,000$366K0.0%N/A0.097%


CTNM Institutional Ownership - Frequently Asked Questions

During the previous two years, 82 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($35.59M), Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.48M), RA Capital Management L.P. ($24.91M), Franklin Resources Inc. ($21.48M), Balyasny Asset Management L.P. ($21.06M), and Perceptive Advisors LLC ($16.40M).Learn more on Contineum Therapeutics' institutional investors.

Of the 78 institutional investors that purchased Contineum Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($2.80M), Perceptive Advisors LLC ($2.32M), RA Capital Management L.P. ($2.18M), Johnson & Johnson ($1.98M), Balyasny Asset Management L.P. ($1.84M), Baker BROS. Advisors LP ($1.34M), and Franklin Resources Inc. ($1.17M).

Institutional investors have bought a total of 13,860,419 shares in the last 24 months. This purchase volume represents approximately $156.85M in transactions.

Of the 13 institutional investors that sold Contineum Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($950.76K), Versant Venture Management LLC ($375.54K), Saturn V Capital Management LP ($241.63K), Baker BROS. Advisors LP ($234.83K), Schonfeld Strategic Advisors LLC ($145.63K), Geode Capital Management LLC ($121.75K), and ADAR1 Capital Management LLC ($91.14K).

Institutional investors have sold a total of 2,359,684 shares in the last 24 months. This volume of shares sold represents approximately $16.48M in transactions.


Related Companies

This page (NASDAQ:CTNM) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel